Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro

Acta Pharmacologica Sinica

Volumn 27, Issue 11, 2006, Pages 1438-1446

  Zhang, Chun ^a   Cui, Guo Hui ^a   Liu, Fang ^a   Wu, Qiu Ling ^a   Chen, Yan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CXCR4; Metastasis; Non Hodgkin's lymphoma; Raji; Stromal cell derived factor 1; Triptolide

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1; TRIPTOLIDE;

ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; LYMPH NODE METASTASIS; NONHODGKIN LYMPHOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS, ALKYLATING; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CXCL12; CHEMOTAXIS; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXY COMPOUNDS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; PHENANTHRENES; PLANTS, MEDICINAL; RECEPTORS, CXCR4; RNA, MESSENGER; STROMAL CELLS; TRIPTERYGIUM;

EID: 33750282749     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00415.x     Document Type: Article

References (23)

1. Chen BJ. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. Leuk Lymphoma 2001; 42: 253-65
2. Yang S, Chen J, Guo Z, Xu XM, Wang L, Pei XF, et al. Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther 2003; 2: 65-72.
3. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999; 286: 2098-102.
4. Muller G, Hopken UE, Lipp M. Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors. J Leukoc Biol 2002; 72: 1-8.
5. Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005; 23: 879-94.
6. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-6.
7. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 2003; 167: 1676-86.
8. Sun YX, Wang J, Shelburne CE, Lopatin DE, Chinnaiyan AM, Rubin MA, et al. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 2003; 89: 462-73.
9. Zhou Y, Larsen PH, Hao C, Yong VW. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 2002; 277: 49481-7.
10. Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, et al. Stromal cell derived factor 1α stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinase 1/2 and Akt. Cancer Res 2003; 63: 1969-74.
11. Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U. Williams Hematology. 4th ed. New York (NY): McGraw-Hill Profession-al; 2000. p1049-57.
12. Bertolini F, Dell'Agnola C, Mancuso P, Rabascio C, Burlini A, Monestiroli S, et al. CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. Cancer Res 2002; 62: 3106-12.
13. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
14. Yinjun L, Jie J, Yungui W. Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells. Leuk Res 2005; 29: 99-105.
15. Lou YJ, Jin J. Triptolide down-regulates bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells. Leuk Lymphoma 2004; 45: 373-6.
16. Chang WT, Kang JJ, Lee KY, Wei K, Anderson E, Gotmare S, et al. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway. J Biol Chem 2001; 276: 2221-7.
17. Zhou YX, Huang YL, Xu QN, Ye M, Sun CF, Zhou D. Several monomes from Tripterygium wilfordii inhibit proliferation of glioma cells in vitro. Ai Zheng 2002; 21: 1106-8.
18. Sanchez-Madrid F, del Pozo MA. Leukocyte polarization in cell migration and immune reactions. EMBO J 1999; 18: 501-11.
19. Trentin L, Cabrelle A, Facco M, Carollo D, Miorin M, Tosoni A, et al. Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood 2004; 104: 502-8.
20. Bradstock KF, Makrynikola V, Bianchi A, Shen W, Hewson J, Gottlieb DJ. Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers. Leukemia 2000; 14: 882-8.
21. 2+ immunophenotype. Am J Clin Pathol 2003; 119: 424-30.
22. Arai J, Yasukawa M, Yakushijin Y, Miyazaki T, Fujita S. Stromal cells in lymph nodes attract B-lymphoma cells via production of stromal cell-derived factor-1. Eur J Haematol 2000; 64: 323-32.
23. Liu F, Cui GH, Zhang C, Wang Y, Chen Y. Effects of triptolide on the expression of vascular endothelial growth factor (VEGF) in cultured Raji cells. Chin Hosp Pharm J 2004; 24: 413-5.